This report is being submitted retrospectively as part of an internal review.The risks identified for the eversense¿ cgm system are common to all cgm systems even though a minor surgical procedure is required for insertion and removal of the sensor.These include local infection, pain or discomfort, inflammation, bleeding at the insertion or removal site, bruising, itching, scarring or skin discoloration, hematoma, erythema, adhesive tape irritation and sensor fracture.There is no remedial action/corrective action/preventive action/field safety corrective action required in this case as the device is not defective.The potential develop pain at the insertion site is a known and anticipated adverse effect of the system.The patient visited the healthcare facility and they decided to remove the sensor on his request.
|
Senseonics was recently made aware of an incident where the patient reported pain and swelling at the insertion site since the insertion of the eversense sensor.The patient went to the hospital to obtain painkillers to reduce the pain and swelling, however, the pain and swelling did not subside.As a result, the sensor was removed from the patient.
|